Topical niclosamide (ATx201) reduces Staphylococcus aureus colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in a randomized, double‐blind, placebo‐controlled Phase 2 trial. - Weiss, Anne; Delavenne, Emilie; Matias, Carina; Lagler, Heimo; Simon, Daniel; Li, Ping; Hansen, Jon U.; dos Santos, Teresa Pires; Jana, Bimal; Priemel, Petra; Bangert, Christine; Bauer, Martin; et al. (Clinical & Translational Medicine, 2022)